StreetAlpha.app
Home › Stocks › ONC

BeOne Medicines Ltd. (ONC)

Healthcare
$390.94
▼ −2.19%
LAST CLOSE · NOV 20

BeOne Medicines makes prescription medicines, including BRUKINSA and TEVIMBRA, and sells them in several countries. It last closed at $390.94 on Nov 20, down 2.19% on the day. The next earnings report for ONC is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, ONC reported EPS of $0.25 on revenue of $1.89B, with revenue up 33.8% from a year ago. Over its last 8 reports the stock moved an average of 3.7% the session after earnings. Over the last 12 months ONC insiders bought $0 of stock on the open market and sold $384.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is ONC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ONC.

Key Stats

Last 12 months
Results
Revenue
$6.6B
+32.9% vs a year ago
Net income
$915.6M
+1235.6% vs a year ago
EPS (diluted)
$0.60
+1400.0% vs a year ago
Free cash flow
$1.4B
21.9% margin
Valuation
Market cap
$581B
1.48B shares
P/E
651.6
Price over 12 month EPS
Price to sales
87.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$5.8B
At Sep 30
Debt
$738.5M
At Sep 30
Shareholder equity
$5.8B
Shares outstanding
1.48B
At Oct 30
Employees12,000 (Sep 30, 2026)
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.2B$1.2BFY2021FY2022: $1.4B$1.4BFY2022FY2023: $2.5B$2.5BFY2023FY2024: $3.8B$3.8BFY2024FY2025: $5.3B$5.3BFY2025

From ONC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · Time not announced
Reported EPS
$0.25
Quarter ended Sep 2026
Year ago EPS
$0.08
+212.5% on a GAAP basis
Revenue
$1.89B
+33.8% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.11Dec '24Mar 2025: $0.00Mar '25Jun 2025: $0.06Jun '25Sep 2025: $0.08Sep '25Dec 2025: $0.04Dec '25Mar 2026: $0.15Mar '26Jun 2026: $0.16Jun '26Sep 2026: $0.25Sep '26Latest $0.25
Revenue by quarter
Dec 2024: $1.13BDec '24Mar 2025: $1.12BMar '25Jun 2025: $1.32BJun '25Sep 2025: $1.41BSep '25Dec 2025: $1.50BDec '25Mar 2026: $1.51BMar '26Jun 2026: $1.71BJun '26Sep 2026: $1.89BSep '26Latest $1.89B
How ONC moved after its last 8 reports
Average move the session after a report ±3.7%
Nov 5, 2026Time not announced+2.5%
Aug 5, 2026Time not announced+1.4%
Apr 14, 2026Time not announced+1.4%
Feb 26, 2026Time not announced−8.5%
Nov 6, 2025Time not announced+3.4%
Aug 6, 2025Time not announced−2.8%
Apr 28, 2025Time not announced+1.9%
Feb 27, 2025Time not announced+7.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ONCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ONC
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ONC

Technical Analysis

ONC · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 16% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot S1 at $384.04, and the nearest resistance the Pivot at $391.90.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 3.0%/day
Key levels
$424.7352 week high+8.6%
$424.73Swing high (Nov 10)+8.6%
$398.80Pivot R1+2.0%
$392.6520 day average+0.4%
$391.90Pivot+0.2%
$390.94Last close
$384.04Pivot S1−1.8%
$374.5750 day average−4.2%
$365.14Swing low (Aug 24)−6.6%
$356.53100 day average−8.8%
$329.24200 day average−15.8%
$253.9552 week low−35.0%
Indicators
RSI (14)49.99Middle of its rangeNeutral
MACD9.72Below its signal lineBearish
Stochastic65.4Middle of its rangeNeutral
ADX (14)18.7No clear trend
Williams %R-43.8Oversold below −80, overbought above −20Neutral
CCI (20)-2.5Oversold below −100, overbought above 100Neutral
Rate of change−3.9%Change over 10 sessionsBearish
ATR (14)$11.58Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ONC

What happened before

See how ONC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ONC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ONC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ONCHow many large options trades hit ONC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

ONC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲204 buying vs 100 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +43
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding327284+15.1%
In funds' top 1065+20.0%
Held by funds2.5%2.4%+0.1 pts
New / increased72 / 13244 / 123+22.2%
Reduced / sold out71 / 2968 / 41−8.3%
Put/call ratio0.971.02−5.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ONC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ONC Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$384.7M51 sales · 12 insiders
97% of the selling was under pre-arranged trading plans.
2025-12 sold $30.9M2026-01 sold $220K2026-02 sold $580K2026-03 sold $102K2026-04 sold $103K2026-05 sold $562K2026-06 sold $7.0M2026-07 sold $208.1M2026-08 sold $87.9M2026-09 sold $25.1M2026-10 sold $22.2M2026-11 sold $1.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 6Titus B. BallPrincipal Accounting OfficerSale1,559$405.57$632K
Nov 5Chan Henry LeeSVP, General CounselSale plan1,115$400.82$447K
Oct 27Xiaodong WangDirectorSale plan31,028$362.97$11.3M
Oct 13Xiaodong WangDirectorSale plan31,027$350.99$10.9M
Sep 30Chan Henry LeeSVP, General CounselSale plan1,115$375.00$418K
Sep 28Xiaodong WangDirectorSale plan31,028$364.79$11.3M
Every insider buy and sale for ONC over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ONC insider trades →

From SEC Form 4 filings by ONC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ONC is in one of them and how their past ONC trades turned out.

ONC in the AI portfolios
Loading…

ONC News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ONC in an article yet. Here's the latest on the wider market.

ONC in the news

About BeOne Medicines

BeOne Medicines makes prescription medicines, including BRUKINSA and TEVIMBRA, and sells them in markets including the U.S., China and Europe. It is headquartered in Basel, Switzerland. Its customers include patients, hospitals and government and private health insurance payors, which set the coverage and reimbursement terms that affect how its medicines are sold.

Headquarters
Basel